The FDA has cleared Tissue Regeneration Systems to market its Cranial Bone Void Filler, a 3D-printed cranial reconstruction device used to close holes in the skulls of patients who have undergone surgery. "To our knowledge, this is the first FDA approval of a coated bioresorbable skeletal reconstruction implant fabricated by means of 3D printing," said Jim Fitzsimmons, the company's president and CEO.
Tissue Regeneration gets FDA OK for 3D-printed cranial reconstruction device
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan